Skip to main content

RETRACTION article

Front. Immunol., 25 September 2024
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1495479

Retraction: CCDC88A post-transcriptionally regulates VEGF via miR-101 and subsequently regulates hepatocellular carcinoma

This article is a retraction of:

  1. RETRACTED: CCDC88A Post-Transcriptionally Regulates VEGF via miR-101 and Subsequently Regulates Hepatocellular Carcinoma

    1. Read original article
Frontiers Editorial Office* Frontiers Editorial Office*

    A retraction of the Original Research article
    CCDC88A post-transcriptionally regulates VEGF via miR-101 and subsequently regulates hepatocellular carcinoma

    By Qiong-ying Hu, Yuchen Li, Hongqing Chen, Hongyan Liao, Yong He, Qin Zheng (2022) Front. Immunol. 13:859331. doi: 10.3389/fimmu.2022.859331

    The journal retracts the April 2022 article cited above.

    Following publication, concerns were raised regarding the validity of the data in the article. An investigation by our internal Research Integrity department, conducted in accordance with Frontiers policies, was unable to confirm the validity of the data presented and we cannot vouch for its reliability. The article is therefore retracted.

    This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.

    Citation: Frontiers Editorial Office (2024) Retraction: CCDC88A post-transcriptionally regulates VEGF via miR-101 and subsequently regulates hepatocellular carcinoma. Front. Immunol. 15:1495479. doi: 10.3389/fimmu.2024.1495479

    Received: 12 September 2024; Accepted: 13 September 2024;
    Published: 25 September 2024.

    Approved by:

    Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland

    Copyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    *Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.